Oxford BioDynamics PLC has released a notification of major holdings, indicating that Spreadex LTD has acquired voting rights in the company. The notification states that Spreadex LTD now holds 5.235100% of voting rights attached to shares, with 1.289400% from direct voting rights and 3.945700% through financial instruments. This amounts to a total of 16,325,725 voting rights held in the issuer. The previous notification showed Spreadex LTD holding 4.761200% of voting rights, indicating an increase in their position.

The breakdown of the voting rights reveals that Spreadex LTD holds 4,020,980 direct voting rights, constituting 1.289400%, and 12,304,745 voting rights through financial instruments, representing 3.945700%. The financial instruments in question are CFD/Spreadbet, with an expiration date and exercise/conversion period specified.

The notification also clarifies that Spreadex LTD, as the person subject to the notification obligation, is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding an interest in the issuer. Additionally, there is no information provided regarding proxy voting.

This notification, dated 11th April 2024, provides an overview of Spreadex LTD's increased holdings and the breakdown of voting rights in Oxford BioDynamics PLC.